eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
3/2013
vol. 9
 
Share:
Share:
more
 
 
abstract:

Special papers
Myocardial infarction caused by pharmacological substances – case description and literature review

Tomasz Kameczura
,
Leszek Bryniarski
,
Sławomir Surowiec
,
Maryla Kocowska
,
Kalina Kawecka-Jaszcz
,
Danuta Czarnecka

Postep Kardiol Inter 2013; 9, 3 (33): 250–255
Online publish date: 2013/09/16
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Myocardial infarction (MI) is most commonly caused by atherosclerosis and/or inflammatory processes of coronary artery walls. The consequence of those phenomena is instability of the atherosclerotic plaque, activation of the coagulation cascade and thrombus formation which occludes the lumen of the vessel. Vasospasm and microembolisation may participate in MI pathogenesis. In young individuals with diagnosis of MI, coronarography often reveals no pathologies. Is reported that MIs without significant changes of the coronary arteries occur in 1% to 12% of patients. In this article we focus on chemical substances, medicines among them, which can be a cause of MI.
keywords:

myocardial infarction, myocardial infarction causes, pharmacotherapy

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe